Previous close | 5.00 |
Open | 5.40 |
Bid | 5.35 |
Ask | 6.05 |
Strike | 200.00 |
Expiry date | 2025-01-17 |
Day's range | 5.40 - 5.75 |
Contract range | N/A |
Volume | |
Open interest | 291 |
Sanofi's (SNY) Dupixent succeeds in a pivotal study for COPD. FDA gives CRL to AbbVie's (ABBV) Parkinson's disease therapy, ABBV-951
High-yield dividend stocks can be great for managing the ongoing reset in global equity markets. Which high-yield dividend stocks are worth buying right now? Read on to find out more about these above-average passive income opportunities.
In the CRL, the FDA asks AbbVie (ABBV) for some extra information about the pump device used to administer the Parkinson's disease medicine, ABBV-951.